These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 20919829)
1. Why target PIM1 for cancer diagnosis and treatment? Magnuson NS; Wang Z; Ding G; Reeves R Future Oncol; 2010 Sep; 6(9):1461-78. PubMed ID: 20919829 [TBL] [Abstract][Full Text] [Related]
2. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. Kim J; Roh M; Abdulkadir SA BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470 [TBL] [Abstract][Full Text] [Related]
4. PIM1 kinase as a target for cancer therapy. Merkel AL; Meggers E; Ocker M Expert Opin Investig Drugs; 2012 Apr; 21(4):425-36. PubMed ID: 22385334 [TBL] [Abstract][Full Text] [Related]
5. Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia. Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Perez M; Muñoz-Galvan S; Cañamero M; Renner O; Carnero A PLoS One; 2013; 8(4):e60277. PubMed ID: 23565217 [TBL] [Abstract][Full Text] [Related]
6. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance. Holder SL; Abdulkadir SA Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399 [TBL] [Abstract][Full Text] [Related]
7. Clinical and therapeutic relevance of PIM1 kinase in gastric cancer. Yan B; Yau EX; Samanta S; Ong CW; Yong KJ; Ng LK; Bhattacharya B; Lim KH; Soong R; Yeoh KG; Deng N; Tan P; Lam Y; Salto-Tellez M; Gastric Cancer; 2012 Apr; 15(2):188-97. PubMed ID: 21993851 [TBL] [Abstract][Full Text] [Related]
8. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis. Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550 [TBL] [Abstract][Full Text] [Related]
9. Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal. Shah N; Pang B; Yeoh KG; Thorn S; Chen CS; Lilly MB; Salto-Tellez M Eur J Cancer; 2008 Oct; 44(15):2144-51. PubMed ID: 18715779 [TBL] [Abstract][Full Text] [Related]
10. NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation. Noura M; Tomita S; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F Cancer Med; 2024 Jul; 13(13):e7445. PubMed ID: 38940430 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. Chen J; Kobayashi M; Darmanin S; Qiao Y; Gully C; Zhao R; Kondo S; Wang H; Wang H; Yeung SC; Lee MH Am J Pathol; 2009 Jul; 175(1):400-11. PubMed ID: 19528349 [TBL] [Abstract][Full Text] [Related]
12. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway. Cao L; Wang F; Li S; Wang X; Huang D; Jiang R Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073 [TBL] [Abstract][Full Text] [Related]
13. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1). Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821 [TBL] [Abstract][Full Text] [Related]
14. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells. Zhang F; Beharry ZM; Harris TE; Lilly MB; Smith CD; Mahajan S; Kraft AS Cancer Biol Ther; 2009 May; 8(9):846-53. PubMed ID: 19276681 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of PIM1 blocks the autophagic flux to sensitize glioblastoma cells to ABT-737-induced apoptosis. Remy J; Linder B; Weirauch U; Konovalova J; Marschalek R; Aigner A; Kögel D Biochim Biophys Acta Mol Cell Res; 2019 Feb; 1866(2):175-189. PubMed ID: 30389373 [TBL] [Abstract][Full Text] [Related]
16. p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase. Zemskova M; Lilly MB; Lin YW; Song JH; Kraft AS Mol Cancer Res; 2010 Aug; 8(8):1126-41. PubMed ID: 20647331 [TBL] [Abstract][Full Text] [Related]
17. The role of PIM1/PIM2 kinases in tumors of the male reproductive system. Jiménez-García MP; Lucena-Cacace A; Robles-Frías MJ; Narlik-Grassow M; Blanco-Aparicio C; Carnero A Sci Rep; 2016 Nov; 6():38079. PubMed ID: 27901106 [TBL] [Abstract][Full Text] [Related]
18. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Zippo A; De Robertis A; Serafini R; Oliviero S Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117 [TBL] [Abstract][Full Text] [Related]
19. PIM1: a promising target in patients with triple-negative breast cancer. Zhao W; Qiu R; Li P; Yang J Med Oncol; 2017 Aug; 34(8):142. PubMed ID: 28721678 [TBL] [Abstract][Full Text] [Related]
20. Identification of quinones as novel PIM1 kinase inhibitors. Schroeder RL; Goyal N; Bratton M; Townley I; Pham NA; Tram P; Stone T; Geathers J; Nguyen K; Sridhar J Bioorg Med Chem Lett; 2016 Jul; 26(13):3187-3191. PubMed ID: 27173800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]